We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Cardiology

Pulmonary Artery Stiffness and Right Ventricular Function: A Superior Predictor of Mortality in Mild Pulmonary Hypertension

MedXY Editorial Team•Aug 28, 2026•Cardiology
Huyết Áp Phổimortality predictionpulmonary artery stiffnessRight Ventricular Function

Highlight

  • Pulmonary artery compliance (PAC), arterial elastance (Ea), and stroke volume index (SVI) independently predict mortality in mild pulmonary hypertension (PH), unlike mean pulmonary artery pressure (mPAP) and pulmonary vascular resistance (PVR).
  • This prognostic significance extends across the full spectrum of PH severity and various etiological subgroups.
  • Parameters integrating pulsatile vascular load and right ventricular (RV) function provide better risk stratification, particularly in early-stage or mild PH, where conventional steady-flow metrics fall short.

Study Background

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Refining Right Ventricular Assessment in Pulmonary Hypertension: Impact of Postprocessing Techniques on Cardiac MRI MetricsThis study examines how cardiac MRI postprocessing methods, including trabeculation exclusion and pulmonary artery flow measurement sites, significantly influence right ventricular volume and function assessment in pulmonary hypertension paSep 17, 2026Distinct Lipid Metabolic Profiles Unveil Pathophysiological Differences Between Postcapillary and Combined Pre- and Postcapillary Pulmonary HypertensionThis study reveals unique fatty acid and oxylipin metabolic signatures that differentiate isolated postcapillary pulmonary hypertension from combined pre- and postcapillary PH, highlighting potential biomarkers and therapeutic targets.Sep 15, 2026Unveiling PUS7’s Role in Pulmonary Hypertension: A Novel Epigenetic Driver of Vascular RemodelingThis article explores how PUS7-induced pseudouridylation of TGFBI mRNA promotes pulmonary hypertension via epigenetic regulation, revealing promising new therapeutic targets.Sep 5, 2026
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
Validating the Venous Excess Ultrasound Score (VExUS) for Right Atrial Pressure Assessment in Pulmonary Hypertension: A Multicenter Study
This multicenter study validates the Venous Excess Ultrasound Score (VExUS) as a highly accurate, noninvasive tool to predict right atrial pressure in patients evaluated for pulmonary hypertension, outperforming isolated echocardiographic m
Sep 3, 2026
Unraveling Right Ventricular Failure in PH-HFpEF: Integrative Insights from Vascular Mechanics and TranscriptomicsThis study integrates vascular mechanics, advanced imaging, and myocardial transcriptomics to elucidate the mechanisms of right ventricular failure in pulmonary hypertension secondary to heart failure with preserved ejection fraction, uncovAug 25, 2026
Sotatercept’s Multifaceted Role in Enhancing Exercise Capacity in Pulmonary Arterial HypertensionSotatercept improves exercise tolerance in pulmonary arterial hypertension through pulmonary vascular remodeling, systemic decongestion with hemoconcentration, improved right ventricular-pulmonary artery coupling, enhanced cardiac output reAug 12, 2026